Prognostic and therapeutic implications of low aortic valve calcium score in patients with low gradient aortic stenosis.

IF 6.7 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
D Juhász, M Vecsey-Nagy, Á L Jermendy, B Szilveszter, J Simon, B Vattay, M Boussoussou, D Dávid, P Maurovich-Horvat, B Merkely, A Apor, L Molnár, E Dósa, M Rakovics, J Johnson, A Manouras, A I Nagy
{"title":"Prognostic and therapeutic implications of low aortic valve calcium score in patients with low gradient aortic stenosis.","authors":"D Juhász, M Vecsey-Nagy, Á L Jermendy, B Szilveszter, J Simon, B Vattay, M Boussoussou, D Dávid, P Maurovich-Horvat, B Merkely, A Apor, L Molnár, E Dósa, M Rakovics, J Johnson, A Manouras, A I Nagy","doi":"10.1093/ehjci/jeae276","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Low gradient (LG) aortic stenosis (AS) poses a diagnostic challenge. Aortic valve calcium score (AVCS) assessment has emerged as a complementary diagnostic method when echocardiography provides discordant results. However, the diagnostic and prognostic value of AVCS in LGAS has not been thoroughly studied. Our aims were to investigate the prognostic importance of AVCS in LGAS and to assess whether symptomatic patients with LGAS and low AVCS may benefit from aortic valve intervention (AVI).</p><p><strong>Methods: </strong>327 symptomatic patients (78.5±7.3 years, 51% women) with severe AS defined by the aortic valve area who underwent computed tomography for transcatheter aortic valve intervention (TAVI) planning were enrolled. AVCS was measured. AVCS<2000 AU in men and<1200 AU in women was considered low AVCS.</p><p><strong>Results: </strong>243 patients had high gradient (HG) and 84 had LGAS. Low AVCS was present in 25(10%) of the HG and 34(40%) of the LGAS cases. Over a median follow-up period of 4.9 years, 194 deaths occurred. In multivariate analysis, AVCS was a significant independent predictor of all-cause mortality among HGAS (aHR:2.317; CI:1.104-4.861; p= 0.026), but not among LGAS (aHR:0.848; CI:0.434-1.658; p=0.630) patients. After propensity score matching between patients who underwent AVI and those who were medically treated, AVI (94% TAVI) was a significant and independent predictor of survival among LG AS patients with low AVCS even after adjustment for clinical variables (aHR:0.102, CI:0.028-0.369; p<0.001).</p><p><strong>Conclusion: </strong>The prevalence of low AVCS is much higher in LGAS than in HGAS. In symptomatic severe LGAS low AVCS did not entail a better prognosis. AVI is equally beneficial in LGAS patients with high or low AVCS, similarly to HGAS.</p>","PeriodicalId":12026,"journal":{"name":"European Heart Journal - Cardiovascular Imaging","volume":" ","pages":""},"PeriodicalIF":6.7000,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal - Cardiovascular Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ehjci/jeae276","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Low gradient (LG) aortic stenosis (AS) poses a diagnostic challenge. Aortic valve calcium score (AVCS) assessment has emerged as a complementary diagnostic method when echocardiography provides discordant results. However, the diagnostic and prognostic value of AVCS in LGAS has not been thoroughly studied. Our aims were to investigate the prognostic importance of AVCS in LGAS and to assess whether symptomatic patients with LGAS and low AVCS may benefit from aortic valve intervention (AVI).

Methods: 327 symptomatic patients (78.5±7.3 years, 51% women) with severe AS defined by the aortic valve area who underwent computed tomography for transcatheter aortic valve intervention (TAVI) planning were enrolled. AVCS was measured. AVCS<2000 AU in men and<1200 AU in women was considered low AVCS.

Results: 243 patients had high gradient (HG) and 84 had LGAS. Low AVCS was present in 25(10%) of the HG and 34(40%) of the LGAS cases. Over a median follow-up period of 4.9 years, 194 deaths occurred. In multivariate analysis, AVCS was a significant independent predictor of all-cause mortality among HGAS (aHR:2.317; CI:1.104-4.861; p= 0.026), but not among LGAS (aHR:0.848; CI:0.434-1.658; p=0.630) patients. After propensity score matching between patients who underwent AVI and those who were medically treated, AVI (94% TAVI) was a significant and independent predictor of survival among LG AS patients with low AVCS even after adjustment for clinical variables (aHR:0.102, CI:0.028-0.369; p<0.001).

Conclusion: The prevalence of low AVCS is much higher in LGAS than in HGAS. In symptomatic severe LGAS low AVCS did not entail a better prognosis. AVI is equally beneficial in LGAS patients with high or low AVCS, similarly to HGAS.

低梯度主动脉瓣狭窄患者主动脉瓣低钙化评分的预后和治疗意义。
导言:低梯度(LG)主动脉瓣狭窄(AS)给诊断带来了挑战。当超声心动图检查结果不一致时,主动脉瓣钙化评分(AVCS)评估成为一种辅助诊断方法。然而,AVCS 在 LGAS 中的诊断和预后价值尚未得到深入研究。我们的目的是研究 AVCS 在 LGAS 中的预后重要性,并评估 LGAS 且 AVCS 低的无症状患者是否能从主动脉瓣介入治疗(AVI)中获益。方法:我们招募了 327 名有症状的患者(78.5±7.3 岁,51% 为女性),这些患者的主动脉瓣面积被定义为重度 AS,他们接受了计算机断层扫描,以制定经导管主动脉瓣介入治疗(TAVI)计划。测量了主动脉瓣狭窄指数(AVCS)。AVCS结果:243名患者为高梯度(HG),84名患者为低梯度(LGAS)。25(10%)名高梯度患者和34(40%)名低梯度患者存在低AVCS。在中位 4.9 年的随访期间,共有 194 人死亡。在多变量分析中,AVCS 是 HGAS(aHR:2.317; CI:1.104-4.861; p=0.026)患者全因死亡率的重要独立预测因素,但不是 LGAS(aHR:0.848; CI:0.434-1.658; p=0.630)患者全因死亡率的重要独立预测因素。在对接受 AVI 的患者和接受药物治疗的患者进行倾向评分匹配后,即使对临床变量进行调整,AVI(94% TAVI)仍是低 AVCS LG AS 患者生存率的重要独立预测因素(aHR:0.102, CI:0.028-0.369; p结论:低AVCS在LGAS中的发病率远高于HGAS。在有症状的重度 LGAS 中,低 AVCS 并不意味着更好的预后。与 HGAS 相似,AVI 对高或低 AVCS 的 LGAS 患者同样有益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Heart Journal - Cardiovascular Imaging
European Heart Journal - Cardiovascular Imaging CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
11.60
自引率
9.70%
发文量
708
审稿时长
4-8 weeks
期刊介绍: European Heart Journal – Cardiovascular Imaging is a monthly international peer reviewed journal dealing with Cardiovascular Imaging. It is an official publication of the European Association of Cardiovascular Imaging, a branch of the European Society of Cardiology. The journal aims to publish the highest quality material, both scientific and clinical from all areas of cardiovascular imaging including echocardiography, magnetic resonance, computed tomography, nuclear and invasive imaging. A range of article types will be considered, including original research, reviews, editorials, image focus, letters and recommendation papers from relevant groups of the European Society of Cardiology. In addition it provides a forum for the exchange of information on all aspects of cardiovascular imaging.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信